11/11/2021 - General information
The AECC has awarded 186 grants in 2021, totalling approximately 20 million euros. Two of these will benefit IMIM researchers, Teresa Lobo, who is receiving a postdoctoral grant, and Arnau Sabater, who has been able to participate in the laboratory internship programme. The Spanish Association Against Cancer awarded its 2021 research grants at a ceremony held on 11 November at its headquarters in Barcelona. In total, 186 projects and nearly 20 million euros have been allocated with the aim of continuing progress into cancer research, focusing on the patient and further increasing cancer survival. In this edition, two researchers linked to the Hospital del Mar Medical Research Institute (IMIM) will benefit from the grants.
Two projects by staff from the Hospital del Mar and the Hospital del Mar Medical Research Institute (IMIM) have been awarded funding by the Spanish Society of Medical Oncology as part of its 2021 grants. The awards were presented on 13 October in Madrid and represent a new record for the organisation, with 44 scholarships and grants awarded with an endowment of nearly 1.4 million euros. All the money is earmarked for research and the training of medical professionals to improve the survival and quality of life of cancer patients.
05/11/2021 - General information
A study led by the Colon and Rectal Surgery Unit, part of the Surgery Service at Hospital del Mar, has received two research grants, one from the Catalan Society of Surgery during the inaugural ceremony of the academic year on 15 October; and another from the Spanish Association of Coloproctology, during the organisation's conference, held from 20 to 22 October. The funding goes towards a multicentre project entitled 'Determining proangiogenic proteins in serum as a prognostic factor for recurrence after curative colon cancer surgery', led by Dr. Marta Pascual, head of the Colon and Rectal Surgery Unit, and Dr. Clara Téllez, a resident in the same department, in collaboration with Dr. Xavier Mayol, a researcher in the Cancer Research Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar).
15/09/2021 - Institutional news
Dr. Pedro Rocha is one of the nine people to receive an award from the European Society of Medical Oncology. In his case, this means joining the lung cancer team at Hospital del Mar led by Dr. Edurne Arriola. He will also take part in the research being carried out by this team at the Hospital del Mar Medical Research Institute in the field of small cell lung cancer. These ESMO Research Fellowship grants allow young doctors and researchers the opportunity to develop a research project in a European reference centre. As explained by Dr. Arriola, "The awarding of this grant establishes Hospital del Mar as a world-class centre of interest in the field of oncology." Dr. Rocha is currently working at the MD Anderson Cancer Centre at the University of Texas, in the United States.
12/08/2021 - Press release
A study led by doctors and researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), and CIBER Oncology (CIBERONC) has demonstrated the role a protein, neuregulin, plays in generating resistance to the most common treatment for HER2-positive breast cancer, one of the most aggressive types. The study, published in the journal Clinical Cancer Research, and in which leading Italian researchers Luca Gianni from the Fondazione Gianni Bonnadonna and Giampaolo Bianchini from the IRCCS Ospedale San Raffaele have collaborated, has identified that in patients with high levels of this protein, the success rate with the monoclonal antibody trastuzumab, the first-line drug, drops. Conversely, when combined with another monoclonal antibody, pertuzumab, the situation is reversed and full pathological response levels are restored.
06/08/2021 - Press release
A Hospital del Mar project to determine new prognostic and predictive markers that could be beneficial in metastatic small cell lung cancer treatment, using genetic analysis techniques, has been awarded $200,000 from the Oncomine Clinical Research Grant programme, promoted by the US-based multinational biotech company Thermo Fisher Scientific, which supports research that enables advances in the field of molecular patient profiling, with the aim of improving clinical outcomes. The research was led by Dr. Edurne Arriola, head of the lung cancer section in the Medical Oncology Service and a researcher at the Hospital del Mar Medical Research Institute (IMIM), and Dr. Beatriz Bellosillo, head of the Medical Oncology Service and also an IMIM researcher. To undertake the project, they will analyse samples from 300 patients with this pathology, collected over the last 10 years. The research will focus on evaluating the potential of the liquid biopsy technique, which can detect DNA from tumour cells in the blood, to monitor the disease and its evolution, as well as detecting potential biomarkers of treatment benefit and predictors of long-term prognosis.
Més informació "$200,000 grant for lung cancer research at Hospital del Mar"
28/07/2021 - General information
On July 19 the Barcelona Biomedical Research Park (PRBB) launched a new science outreach product, "La mare de la ciència", a podcast in Catalan where you can "listen to science" done at the Park. During the second half of July the six episodes that make up the first season will be released. Today, July 28th, the podcast of Toni Celià-Terrassa, group leader of the Cancer Stem Cells and Metastasis Dynamics group at the IMIM, will be launched and will help us to decipher metastasis. This is a narrative podcast in short format, where Marta Vila, from the PRBB's communication department, leads us through the research and stories of six researchers from the Park's centres. A very personal and close look to the science that is done in the PRBB and the people behind it.
Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumor, which has no cure in the most advanced stages or cases of relapse.
Més informació "A new approach to metastatic melanoma discovered"
Dr Joan Albanell, head of the Medical Oncology Department at Hospital del Mar and director of the Cancer Research Programme at the Hospital del Mar Medical Research Institute, is one of the authors of the first article to come out of this study, in which more than sixty hospitals from eleven European countries are taking part. The work, published in the prestigious journal Cancer Discovery, is an important step in understanding the molecular changes that lead to metastasis in breast cancer.
21/06/2021 - Press release
As a result of the collaboration between research centres in Italy and Spain, the PEGASUS study has been launched with the aim of demonstrating that, thanks to the liquid biopsy guidance tool, it is possible to increase the precision of post-surgical treatment for colon cancer patients. The Vall d'Hebron Institute of Oncology (VHIO), part of the Vall d'Hebron Campus, and the Hospital del Mar Medical Research Institute (IMIM), both in Barcelona; and the INCLIVA Health Research Institute at Hospital Clínico in Valencia, are the three Spanish centres taking part in this project. The study was instigated by Dr. Silvia Marsoni, from the FIRC Institute of Molecular Oncology (IFOM) in Milan, and is supported by the AIRC Foundation within the 5x1000 programme, which is coordinated by Prof. Alberto Bardelli of the University of Turin and the Institute of Candiolo FPO-IRCCS.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
